Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Pacira (PCRX) Up on Data From Exparel Label Expansion Study

02:42pm, Thursday, 08'th Sep 2022 Zacks Investment Research
Pacira (PCRX) reports encouraging top-line data from the phase III study evaluating Exparel as a single-dose femoral nerve block in the adductor canal for total knee arthroplasty. Shares rise.
Gainers Asana, Inc. (NYSE: ASAN) rose 24.1% to $23.62 in pre-market trading after the company reported better-than-expected results for its second quarter and issued a strong sales guidance. AcelRx
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) shares gained 66.5% to close at $7.51 after Point72 Asset Management reported an 8.8% passive stake in the company. SuperCom Ltd. (NASDAQ: SPCB) jum
Oral presentation will feature results from Part A of the Phase 2/3 RINGSIDE clinical study Oral presentation will feature results from Part A of the Phase 2/3 RINGSIDE clinical study
The beaten-down stock market has created an opportunity for contrarian investors in short-squeeze stocks. Essentially, bearish traders must borrow the underlying securities which they are pessimistic

Ayala Pharmaceuticals, Inc. (AYLA) Reports Q2 Loss, Misses Revenue Estimates

09:25pm, Monday, 15'th Aug 2022 Zacks Investment Research
Ayala Pharmaceuticals, Inc. (AYLA) delivered earnings and revenue surprises of 20.59% and 95.17%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the st
Interim data from Part A of the RINGSIDE study demonstrated substantial initial anti-tumor activity for AL102 as a single agent and supports continued development
Ayala Pharmaceuticals, Inc. (AYLA) delivered earnings and revenue surprises of 20.59% and 95.17%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the st

ProPhase Labs, Inc. (PRPH) Tops Q2 Earnings and Revenue Estimates

01:25pm, Thursday, 11'th Aug 2022 Zacks Investment Research
ProPhase Labs, Inc. (PRPH) delivered earnings and revenue surprises of 233.33% and 28.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Tops Revenue Estimates

10:25pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Infinity (INFI) delivered earnings and revenue surprises of 7.14% and 1.63%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

PTC Therapeutics (PTCT) Reports Q2 Loss, Tops Revenue Estimates

10:35pm, Thursday, 04'th Aug 2022 Zacks Investment Research
PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -27.54% and 13.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Hot low float penny stocks to watch. The post Penny Stocks To Buy Now? 3 To Watch After LTRPB Stock Jumped Over 372% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
Hot low float penny stocks to watch. The post Penny Stocks To Buy Now?
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdin
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders. NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) rose 91.1% t
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE